MicroMend

MicroMend Overview

Status Private
Latest Deal Type Later Stage VC
Latest Deal Amount $3.43M
Latest Deal Amount
Investors 11

MicroMend General Information

Description

Developer of wound closure device designed to provide a new alternative to sutures and staples for skin closure. The company's device has the added feature of tiny micro staples that allow it to achieve similar holding strength to sutures, and thus close wounds currently requiring sutures or staples, enabling medical practitioners to treat skin wounds like surgical incisions and lacerations.

Contact Information

Formerly Known As
Marco Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Primary Office
  • 500 Yale Avenue North
  • Suite 100
  • Seattle, WA 98109
  • United States
+1 (206) 000-0000

MicroMend Timeline

2017201820192020
Financing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroMend Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 21-Nov-2019 $3.43M 00.000 Completed Generating Revenue
5. Later Stage VC (Series A) 01-Jun-2018 00.000 Completed Generating Revenue
4. Later Stage VC (Series A1) 02-Mar-2017 00000 00.000 00.00 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Dec-2014 00.000 00.000 00.000 Completed Generating Revenue
2. Grant 01-Dec-2012 $1.75M $15K Completed Generating Revenue
1. Early Stage VC 01-Jan-2010 $15K $15K Completed Startup

MicroMend Cap Table

To view MicroMend‘s complete cap table, request access >>
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A1 0,000,000 00.000000 00.0 00.0 00 00.0 0.000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000

MicroMend Competitors (14)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
FzioMed Venture Capital-Backed San Luis Obispo, CA 00 000.00 0000000000 0 000.00
0000000 Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
0000000 0000000 Formerly VC-backed Campbell, CA 00 000.00 000000&0 000.00
000000000 Venture Capital-Backed Leeds, United Kingdom 00 000.00 00000000000 000.00
00000000 Formerly VC-backed Mason, OH 000 0000 00000000 0000

MicroMend Executive Team (3)

Name Title Board Seat Contact Info
Ronald Berenson MD Co-Founder, President, Chief Executive Officer and Board Member
Marco Rolandi Ph.D Co-Founder & CSO

1 Former Executive

MicroMend Board Members (8)

To view MicroMend‘s full board member team, request access >>
Name Representing Role Since
Cameron Pollock Self Board Member 000 0000
Edward Truitt JD Self Board Member 000 0000
Henry Kim Self Board Member 000 0000
Jens Quistgaard Ph.D Self Board Member 000 0000
John Brzezenski Self Board Member 000 0000

1 Former Board Member

MicroMend Investors (11)

To view MicroMend‘s full investor history, request access >>
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Elevate Capital Venture Capital Minority 000 0000 000000 0
Thynk Capital Venture Capital Minority 000 0000 000000 0
Cornerstone Angels Angel Group Minority 000 0000 000000 0
HBS Alumni Angels New York Angel Group Minority 000 0000 000000 0
Imre Eszenyi Angel (individual) Minority 000 0000 000000 0

Ready to get started?

Request a free trial